You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Details for Patent: 5,376,634


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,376,634
Title: Polypeptide compound and a process for preparation thereof
Abstract:A polypeptide compound having antimicrobial activity of the following general formula: ##STR1## wherein R.sup.1 is hydrogen or acyl group, R.sup.2 is hydroxy or acyloxy, R.sup.3 is hydroxysulfonyloxy, and R.sup.4 is hydrogen or carbamoyl, with proviso that R.sup.1 is not palmitoyl, when R.sup.2 is hydroxy, R.sup.3 is hydroxysulfonyloxy and R.sup.4 is carbamoyl, and a pharmaceutically acceptable salt thereof.
Inventor(s): Iwamoto; Toshiro (Tsukuba, JP), Fujie; Akihiko (Tsuchiura, JP), Nitta; Kumiko (Tsuchiura, JP), Tsurumi; Yasuhisa (Tsukuba, JP), Shigematsu; Nobuharu (Tsukuba, JP), Kasahara; Chiyoshi (Ikeda, JP), Hino; Motohiro (Tsuchiura, JP), Okuhara; Masakuni (Tsukuba, JP), Sakane; Kazuo (Kawanishi, JP), Kawabata; Kohji (Kawanishi, JP), Ohki; Hidenori (Ikeda, JP)
Assignee: Fujisawa Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:07/715,961
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 5,376,634

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,376,634

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9013558Jun 18, 1990
United Kingdom9023666Oct 31, 1990
United Kingdom9101552Jan 24, 1991

International Family Members for US Patent 5,376,634

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 125550 ⤷  Try a Trial
Austria 143671 ⤷  Try a Trial
Australia 651347 ⤷  Try a Trial
Australia 6655790 ⤷  Try a Trial
Australia 7843591 ⤷  Try a Trial
Canada 2029766 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.